囊状支气管扩张术后咯血复发预测列线图表1
用于预测囊状支气管扩张患者介入术后咯血复发的列线模型数据表,包含预测因子和模型评估结果。

基本信息
资源简介
囊状支气管扩张术后咯血复发预测列线图表1
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 290.60 KB,主题涵盖 cystic bronchiectasis、nomogram、hemoptysis、bronchial artery embolization、recurrence prediction,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Table 1_Development and validation of a nomogram for predicting hemoptysis recurrence in cystic bronchiectasis patients following bronchial artery embolization.docx》。配套论文《Embosphere microspheres size for bronchial artery embolization in patients with hemoptysis caused by bronchiectasis: a retrospective comparative analysis of 500–750 versus 700–900 μm microspheres》发表于 BMC Pulmonary Medicine(2024),DOI:10.1186/s12890-024-03019-4。源站首次发布:2025-05-15。
【数据内容】
源站原始描述:BackgroundHemoptysis is a life-threatening manifestation frequently observed in patients with cystic bronchiectasis (CB), a radiologically defined subtype of bronchiectasis. Bronchial artery embolization (BAE) is widely employed as an effective interventional therapy for controlling hemoptysis. Despite its clinical utility, the risk of recurrence remains high, particularly in patients with CB. Currently, no reliable predictive model specifically targeting CB-related hemoptysis recurrence followi…
【数据结构与技术规格】
文件数 1 个,合计 290.60 KB。Table 1_Development and validation of a nomogram for predicting hemoptysis recurrence in cystic bronchiectasis patients following bronchial artery emb.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,290.60 KB。数据集 DOI:10.3389/fmed.2025.1582008.s001。
【主题与分类】
源站学科分类:Foetal Development and Medicine。主题标签:cystic bronchiectasis、nomogram、hemoptysis、bronchial artery embolization、recurrence prediction。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/Table_1_Development_and_validation_of_a_nomogram_for_predicting_hemoptysis_recurrence_in_cystic_bronchiectasis_patients_following_bronchial_artery_embolization_docx/29068376
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Duan, Yuxin; Sui, Weifan; Cai, Zefeng; Xia, Yimao; Li, Jianyun; Fu, Jianhua (2025). Table 1_Development and validation of a nomogram for predicting hemoptysis recurrence in cystic bronchiectasis patients following bronchial artery embolization.docx. Frontiers. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Table 1_Development and validation of a nomogram for predicting hemoptysis recurrence in cystic bronchiectasis patients following bronchial artery embolization.docx
- DOI:10.3389/fmed.2025.1582008.s001
- 发布日期:2025-05-15
- 文件数:1 个
- 文件总体积:290.60 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/Table_1_Development_and_validation_of_a_nomogram_for_predicting_hemoptysis_recurrence_in_cystic_bronchiectasis_patients_following_bronchial_artery_embolization_docx/29068376
命令行下载
curl -L -o "Table 1_Development and validation of a nomogram for predicting hemoptysis recurrence in cystic bronchiectasis patients following bronchial artery emb.docx" "https://ndownloader.figshare.com/files/54549545"
文件清单
Table 1_Development and validation of a nomogram for predicting hemoptysis recurrence in cystic bronchiectasis patients following bronchial artery emb.docx(290.60 KB)
文件总体积 290.60 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
BackgroundHemoptysis is a life-threatening manifestation frequently observed in patients with cystic bronchiectasis (CB), a radiologically defined subtype of bronchiectasis. Bronchial artery embolization (BAE) is widely employed as an effective interventional therapy for controlling hemoptysis. Despite its clinical utility, the risk of recurrence remains high, particularly in patients with CB. Currently, no reliable predictive model specifically targeting CB-related hemoptysis recurrence following BAE has been established, highlighting the need for a tailored prognostic tool in this population.
ObjectiveThis study aimed to develop and validate a model to predict the recurrence of hemoptysis in CB patients following BAE, enabling individualized clinical management and prevention strategies.
MethodsA retrospective study was conducted on 111 CB patients who underwent BAE between January 2015 and June 2020. Clinical, radiological, and laboratory data were collected for analysis. Least absolute shrinkage and selection operator (LASSO) regression was applied to identify relevant predictive variables, followed by multivariable Cox proportional hazards regression to determine independent prognostic factors. Based on these predictors, a nomogram was constructed. Its performance was assessed using the concordance index (C-index), receiver operating characteristic (ROC) curves, area under the curve (AUC), calibration plots, and decision curve analysis (DCA).
ResultsFive independent predictors were identified: history of hemoptysis (HR = 3.42, 95% CI: 1.64–7.12, p = 0.001), diabetes (HR = 15.0, 95% CI: 4.69–48.1, p The nomogram is a reliable tool for predicting hemoptysis recurrence in CB patients after BAE. It facilitates early identification of high-risk patients, enabling timely, targeted interventions and improved outcomes.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fmed.2025.1582008.s001(source: https://frontiersin.figshare.com/articles/dataset/Table_1_Development_and_validation_of_a_nomogram_for_predicting_hemoptysis_recurrence_in_cystic_bronchiectasis_patients_following_bronchial_artery_embolization_docx/29068376)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




